Houston Methodist. Leading Medicine.
Houston Methodist. Leading Medicine

Arturas Ziemys Ph.D.

Arturas Ziemys, Ph.D. 

Arturas Ziemys, Ph.D.

Arturas Ziemys, Ph.D.

Assistant Member
The Department of Nanomedicine
The Methodist Hospital Research Institute

E-mail: aziemys@houstonmethodist.org
Phone: 713-441-7320


Education

B.S.   Vytautas Magnus University, Kaunas, Lithuania (Biology)
M.S.   Vytautas Magnus University, Kaunas, Lithuania  (Molecular Biology & Biotechnology)
Ph.D.   Vytautas Magnus University/Institute of Biochemistry, Kaunas, Lithuania  (Molecular Biophysics)

Postdoctoral Training

Ohio State University, Columbus, OH (Molecular Biophysics)

The University of Texas Health Science Center, Houston, Texas (Nanofluidics)
 

Biography

Dr. Ziemys earned his Ph.D. in Molecular Biophysics from the Vytautas Magnus University in 2002. He held a faculty appointment at Vytautas Magnus University and the position of staff scientist at the Institute of Biochemistry. Dr. Ziemys earned two awards from the Lithuanian Academy of Sciences during this period of time. The main focus of his research was biocatalysis using experimental and computational methods. He left for postdoctoral training at the Ohio State University in 2005, where he studied protein structure under ambient and extreme conditions. Dr. Ziemys continued his training at the University of Texas Health Science Center from 2009 to 2010, focusing on biophysical aspects of nanofluidics and drug delivery. While at the University of Texas Health Science Center he was awarded a postdoctoral fellowship, and worked on a research project that won a national competition to be performed in space.

Description of Research

Dr. Ziemys's research program focuses on nanofluidics, drug delivery, drug design, and interface phenomena for biomedical applications. His current research aims are the development of therapeutic agent mass transport and zero-order drug delivery mechanisms.

Major Areas of Research

Diffusion, drug development, nanofluidics, particulate materials, model systems

Recent Publications

Ziemys A, Grattoni A, Fine D, Hussain F, Ferrari M. Confinement effects on monosaccharides transport in nanochannels. Journal of Physical Chemistry B. 2010; 114(34): 11117-11126.

Fine A, Grattoni A, Hosali S, Ziemys A, De Rosa E, Gill J, Medema R, Hudson L, Kojic M, Milosevic M, Brousseau III L, Goodall R, Ferrari M, Liu X. A robust nanofluidic membrane with tunable zero-order release for implantable dose specific drug delivery. Lab on a Chip. 2010; DOI: 10.1039/c0lc00013b

Grattoni A, Shen H, Fine D, Ziemys A, Gill JS, Hudson L, Hosali S, Goodall R, Liu X, Ferrari M. Nanochannel Technology for Constant Delivery of Chemotherapeutics: Beyond Metronomic Administration. Pharmaceutical Research. 2010; DOI: 10.1007/s11095-010-0195-6.

Grattoni A, Fine D, Ziemys A, Gill J, Zabre E, Goodall R, Ferrari M. Nanochannel Systems for Personalized Therapy and Laboratory Diagnostics. Current Pharmaceutical Biotechnology. 2010; 11(4): 343-365.

Sakamoto J, van de Ven AL, Godin B, Blanco E, Serda RE, Grattonia A, Ziemys A, Bouamrani A, Hu T, Ranganathan SI, De Rosa E, Martinez JO, Smid CA, Buchanan RM, Lee SY, Srinivasana S, Landry M, Meyn A, Tasciotti E, Liua X, Decuzzia P, Ferrari M.. Enabling individualized therapy through nanotechnology. Pharmacological Research. 2010; 62(2): 57-89.